Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
52
Views
4
CrossRef citations to date
0
Altmetric
Review

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

Zeyad Kanaan1 Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA
,
Goetz H Kloecker1 Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA
,
Ajit Paintal2 Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
&
Cesar A Perez1 Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USACorrespondence[email protected]
Pages 885-892 | Published online: 20 Apr 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Srividya Srinivasamaharaj, Bilal Khameze Salame, Jorge Rios-Perez, Goetz Kloecker & Cesar A. Perez. (2016) The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer. Expert Review of Anticancer Therapy 16:12, pages 1227-1233.
Read now
Liting Guo, Haijun Zhang, Weiwei Shao & Baoan Chen. (2015) Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer. Drug Design, Development and Therapy 9, pages 5491-5497.
Read now

Articles from other publishers (2)

Mingxiang Ye, Xinxin Zhang, Nan Li, Yong Zhang, Pengyu Jing, Ning Chang, Jianxiong Wu, Xinling Ren & Jian Zhang. (2016) ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance. Oncotarget 7:11, pages 12289-12304.
Crossref
Ling Hu, Junmei Ai, Hui Long, Weijun Liu, Xiaomei Wang, Yi Zuo, Yan Li, Qingming Wu & Youping Deng. (2016) Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget 7:8, pages 8441-8454.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.